#NetizensVoice
VivaTaiwan Campaign on Twitter
(26 May)Brazilian councillor shared a threatening letter issued on 13 May by the Chinese Communist Party (CCP) in the tweet and said the Chinese embassy had recommended that Brazilian lawmakers stay silent regarding Tsai's inauguration.
Netizens in Brazil expressed their dissatisfaction with Beijing by starting a "VivaTaiwan" (Long live Taiwan) campaign on Twitter. "VivaTaiwan" became a trend on Twitter and netizens printed the letter on toilet paper as a derivative work.
Source: Origos, Twitter
#Brazil #VivaTaiwan #Taiwan #GlobalSupport #ChinaInfluence
VivaTaiwan Campaign on Twitter
(26 May)Brazilian councillor shared a threatening letter issued on 13 May by the Chinese Communist Party (CCP) in the tweet and said the Chinese embassy had recommended that Brazilian lawmakers stay silent regarding Tsai's inauguration.
Netizens in Brazil expressed their dissatisfaction with Beijing by starting a "VivaTaiwan" (Long live Taiwan) campaign on Twitter. "VivaTaiwan" became a trend on Twitter and netizens printed the letter on toilet paper as a derivative work.
Source: Origos, Twitter
#Brazil #VivaTaiwan #Taiwan #GlobalSupport #ChinaInfluence
Brazilian Federal Government Unwilling to Buy Chinese Vaccines, Only Buying Products Developed by British Pharmaceutical Companies and Oxford University
In an interview with local Brazilian media on 14th October, Sao Paulo State Health Secretary Jean Gorinchteyn confirmed that the Brazilian federal government had not appropriated funds to purchase the Wuhan Virus vaccine (CoronaVac) from China. Clinical trials of CoronaVac are being conducted in Brazil and the Butantan Institute of Sao Paulo State is in collaboration with research and development.
Gorinchteyn had also stated that in an earlier Ministry of Health meeting, the Brazilian federal government had confirmed they would only purchase vaccines jointly developed by British pharmaceutical company AstraZeneca and Oxford University and were not planning on purchasing CoronaVac. Besides the guaranteed purchase of 61 million doses of the Oxford vaccines that the Brazilian federal government had already committed to, authorities are unwilling to purchase additional vaccines, but did not explain the reason why funds were not appropriated to buy the Chinese vaccine.
#WuhanVirus #Brazil #vaccines #AstraZeneca #CoronaVac #Oxford #UK
Source: Stand News #Oct16
In an interview with local Brazilian media on 14th October, Sao Paulo State Health Secretary Jean Gorinchteyn confirmed that the Brazilian federal government had not appropriated funds to purchase the Wuhan Virus vaccine (CoronaVac) from China. Clinical trials of CoronaVac are being conducted in Brazil and the Butantan Institute of Sao Paulo State is in collaboration with research and development.
Gorinchteyn had also stated that in an earlier Ministry of Health meeting, the Brazilian federal government had confirmed they would only purchase vaccines jointly developed by British pharmaceutical company AstraZeneca and Oxford University and were not planning on purchasing CoronaVac. Besides the guaranteed purchase of 61 million doses of the Oxford vaccines that the Brazilian federal government had already committed to, authorities are unwilling to purchase additional vaccines, but did not explain the reason why funds were not appropriated to buy the Chinese vaccine.
#WuhanVirus #Brazil #vaccines #AstraZeneca #CoronaVac #Oxford #UK
Source: Stand News #Oct16
立場新聞 Stand News
【武漢肺炎】巴西聯邦政府不願買中國疫苗 只會採購英藥廠與牛津研發產品 | 立場報道 | 立場新聞
周三 (14/10) ，巴西聖保羅州衞生部部長 Jean Gorinchteyn 接受當地傳媒訪問時確認，聯邦...
Brazil President Refused to Buy Chinese Vaccine
Brazil, where the COVID-19 epidemic is severe, plans to launch a national vaccination program. The authorities once stated that they would use a Chinese vaccine, but this action aroused public opposition. Brazilian President Jair Bolsonaro said that he would not buy the Chinese vaccine.
BBC reported that a Bolsonaro supporter urged the authorities not to buy coronavirus vaccine from Sinovac, a Chinese company, on social media, to which Bolsonaro responded, "We will not buy the Chinese vaccine." He added that the Brazilian authorities have not yet approved the use of Sinovac vaccine.
São Paulo Governor João Doria once said the federal government would include CoronaVac, the vaccine from Sinovac, in National Vaccination Program, and agreed to purchase 46 million doses for the citizen of São Paulo. The vaccination program was planned to begin in January 2021. The Health Minister Eduardo Pazuello said on Tuesday (20 October) that the authorities would buy CoronaVac, but Bolsonaro directly rejected it.
#Brazil #NationalImmunizationProgram #Bolsonaro #JoãoDoria #EduardoPazuello #Sinovac #CoronaVac #BBC #COVID19 #ChineseVaccine
Source: The Stand News #Oct22
https://bit.ly/323uY0T
Brazil, where the COVID-19 epidemic is severe, plans to launch a national vaccination program. The authorities once stated that they would use a Chinese vaccine, but this action aroused public opposition. Brazilian President Jair Bolsonaro said that he would not buy the Chinese vaccine.
BBC reported that a Bolsonaro supporter urged the authorities not to buy coronavirus vaccine from Sinovac, a Chinese company, on social media, to which Bolsonaro responded, "We will not buy the Chinese vaccine." He added that the Brazilian authorities have not yet approved the use of Sinovac vaccine.
São Paulo Governor João Doria once said the federal government would include CoronaVac, the vaccine from Sinovac, in National Vaccination Program, and agreed to purchase 46 million doses for the citizen of São Paulo. The vaccination program was planned to begin in January 2021. The Health Minister Eduardo Pazuello said on Tuesday (20 October) that the authorities would buy CoronaVac, but Bolsonaro directly rejected it.
#Brazil #NationalImmunizationProgram #Bolsonaro #JoãoDoria #EduardoPazuello #Sinovac #CoronaVac #BBC #COVID19 #ChineseVaccine
Source: The Stand News #Oct22
https://bit.ly/323uY0T
Hundreds of People Protested Against the Push for Chinese Vaccination in Brazil São Paulo
More than 300 people demonstrated in the central business district of São Paolo, the biggest city in Brazil, on Sunday local times (Nov 1), opposing the measures suggested by the state governor João Doria on the universal COVID-19 vaccination, as well as opposing the authorities on the use of vaccines from a Chinese company Sinovac Biotech.
Protest participants expressed support for President Jair Bolsonaro, who opposed the use of Chinese vaccines. Some even viewed João Doria as China’s ambassador, forcing them to take the Chinese vaccines.
Doria earlier stated that as long as the vaccines were available and sufficient, he planned to force the citizens of São Paolo to vaccinate. However, President Bolsonaro indicated earlier that vaccination was only voluntary. Reports stated that the local Supreme Court would make a verdict on the issue later.
Source: Stand News #Nov02
#Wuhan #Coronavirus #COVID19 #COVID #SaoPaolo #Brazil #JoaoDoria #Doria #JairBolsonaro #Bolsonaro #Vaccines #ChineseVaccine #SinovacBiotech
https://bit.ly/2GMMaQZ
More than 300 people demonstrated in the central business district of São Paolo, the biggest city in Brazil, on Sunday local times (Nov 1), opposing the measures suggested by the state governor João Doria on the universal COVID-19 vaccination, as well as opposing the authorities on the use of vaccines from a Chinese company Sinovac Biotech.
Protest participants expressed support for President Jair Bolsonaro, who opposed the use of Chinese vaccines. Some even viewed João Doria as China’s ambassador, forcing them to take the Chinese vaccines.
Doria earlier stated that as long as the vaccines were available and sufficient, he planned to force the citizens of São Paolo to vaccinate. However, President Bolsonaro indicated earlier that vaccination was only voluntary. Reports stated that the local Supreme Court would make a verdict on the issue later.
Source: Stand News #Nov02
#Wuhan #Coronavirus #COVID19 #COVID #SaoPaolo #Brazil #JoaoDoria #Doria #JairBolsonaro #Bolsonaro #Vaccines #ChineseVaccine #SinovacBiotech
https://bit.ly/2GMMaQZ
Brazil Halts the Final Stage China Vaccine Trial, Claims Serious Adverse Reaction
The Brazilian National Health Surveillance Agency on Monday announced that it has suspended the clinical trials of China's Sinovac COVID-19 vaccines, citing "serious adverse reactions" that occurred during the testing last month (29 October), But the authority did not provide further details, nor explained why it took more than a week to announce the problem.
Sinovac Biotech has been cooperating with Butantan, an institute at the State of Sao Paulo, to develop COVID-19 vaccines, called CoronaVac. The institute was surprised by ANVISA's decision, said it said was investigating the incident and will held a press conference on Tuesday morning local time.
#China #Brazil #SaoPaulo #SinovacBiotech #Butantan #CoronaVac #ANVISA #COVID19 #WuhanVirus #Vaccine
Source: Stand News #Nov10
https://bit.ly/2H6uwYI
The Brazilian National Health Surveillance Agency on Monday announced that it has suspended the clinical trials of China's Sinovac COVID-19 vaccines, citing "serious adverse reactions" that occurred during the testing last month (29 October), But the authority did not provide further details, nor explained why it took more than a week to announce the problem.
Sinovac Biotech has been cooperating with Butantan, an institute at the State of Sao Paulo, to develop COVID-19 vaccines, called CoronaVac. The institute was surprised by ANVISA's decision, said it said was investigating the incident and will held a press conference on Tuesday morning local time.
#China #Brazil #SaoPaulo #SinovacBiotech #Butantan #CoronaVac #ANVISA #COVID19 #WuhanVirus #Vaccine
Source: Stand News #Nov10
https://bit.ly/2H6uwYI
#WuhanPneumonia #CCPVaccine
#Brazil Health Regulator Condemns China For Not Being Transparent
Brazil health regulator #Anvisa releases a statement, criticising that China’s health authorities were not transparent and didn’t provide any information of the criteria for the approval of the emergency use of COVID-19 vaccine developed by China SinoVac Biotech Ltd since June 2020.
China's #SinoVac is conducting the phase 3 tests in different locations, such as Brazil, Indonesia and Turkey, but it doesn’t publish any testing result and efficacy of the vaccine.
The vaccine trial had been suspended because one of the volunteers died. After investigation, the authorities claimed the cause of death was "not related" to the vaccine.
Source: NOW news #Dec15
https://news.now.com/home/international/player?newsId=416739
#Brazil Health Regulator Condemns China For Not Being Transparent
Brazil health regulator #Anvisa releases a statement, criticising that China’s health authorities were not transparent and didn’t provide any information of the criteria for the approval of the emergency use of COVID-19 vaccine developed by China SinoVac Biotech Ltd since June 2020.
China's #SinoVac is conducting the phase 3 tests in different locations, such as Brazil, Indonesia and Turkey, but it doesn’t publish any testing result and efficacy of the vaccine.
The vaccine trial had been suspended because one of the volunteers died. After investigation, the authorities claimed the cause of death was "not related" to the vaccine.
Source: NOW news #Dec15
https://news.now.com/home/international/player?newsId=416739
The Brazilian President Jair Bolsonaro Continued to Criticize China's Vaccine with Low Effectiveness
The Sao Paulo State in Brazil planned to use the Wuhan Virus vaccine developed by Sinovac from China. But President Jair Bolsonaro continued to judge this vaccine, saying that its effectiveness was seemingly low.
Bolsonaro made a Christmas speech on the internet on Thursday saying "The effectiveness of the vaccine which used by Sao Paulo State is relatively low”. But he did not make further explanations. He also indicated earlier that he would not inject this vaccine.
Source from: Apple Daily #Dec25
https://hk.appledaily.com/international/20201225/XZOOEURQHBBHDENNGW6GVJMTQQ/
#Brazil #China #WuhanVirus #Vaccine #Sinovac #JairBolsonaro #COVID19
The Sao Paulo State in Brazil planned to use the Wuhan Virus vaccine developed by Sinovac from China. But President Jair Bolsonaro continued to judge this vaccine, saying that its effectiveness was seemingly low.
Bolsonaro made a Christmas speech on the internet on Thursday saying "The effectiveness of the vaccine which used by Sao Paulo State is relatively low”. But he did not make further explanations. He also indicated earlier that he would not inject this vaccine.
Source from: Apple Daily #Dec25
https://hk.appledaily.com/international/20201225/XZOOEURQHBBHDENNGW6GVJMTQQ/
#Brazil #China #WuhanVirus #Vaccine #Sinovac #JairBolsonaro #COVID19
New Brazil data shows disappointing 50.4% efficacy for China's CoronaVac vaccine
On Jan 12, researches said that a coronavirus vaccine developed by China’s Sinovac Biotech was just 50.4% effective, barely enough for regulatory approval and well below the rate announced a week before, at preventing symptomatic infections in a Brazilian trial.
Researchers at Butantan delayed announcement of their results three times, blaming a confidentiality clause in a contract with Sinovac.
Butantan officials said the design of the Brazilian study, focusing on frontline health workers during a severe outbreak in Brazil and including elderly volunteers, made it impossible to compare the results directly with other trials or vaccines.
Source: Reuters #Jan13
https://www.reuters.com/article/us-health-coronavirus-brazil-coronavirus/brazil-researchers-report-more-modest-50-4-efficacy-for-chinas-coronavac-idUSKBN29H2CE
#Brazil #Sinvac #Covid19Vaccine #VaccinTrial
On Jan 12, researches said that a coronavirus vaccine developed by China’s Sinovac Biotech was just 50.4% effective, barely enough for regulatory approval and well below the rate announced a week before, at preventing symptomatic infections in a Brazilian trial.
Researchers at Butantan delayed announcement of their results three times, blaming a confidentiality clause in a contract with Sinovac.
Butantan officials said the design of the Brazilian study, focusing on frontline health workers during a severe outbreak in Brazil and including elderly volunteers, made it impossible to compare the results directly with other trials or vaccines.
Source: Reuters #Jan13
https://www.reuters.com/article/us-health-coronavirus-brazil-coronavirus/brazil-researchers-report-more-modest-50-4-efficacy-for-chinas-coronavac-idUSKBN29H2CE
#Brazil #Sinvac #Covid19Vaccine #VaccinTrial
Brazil to Look into Banning Companies that Use 5G Equipment from Huawei
In support of the US’s Clean Network Program, Brazil was looking into legal procedures to restrict national telecommunication companies from using 5G network equipment developed by Huawei. Brazilian President Jair Bolsonaro’s national security advisor was looking into whether or not the government should ban Huawei with a presidential decree. However, as many major telecommunication companies have partnered with Huawei for years, the move was expected to be met with strong opposition.
A report stated that the Secretary of Institutional Security Augusto Heleno was in discussions with the Ministry of Communications to set up security provisions that telecommunication companies and equipment suppliers must comply to. They were also studying into the feasibility of a presidential decree. The US has criticised Huawei for its ties with China’s People’s Liberation Army and has expressed concerns over the leaking of confidential information to the Chinese government, which presents threats to national security.
As China has been Brazil’s most important trade partner, the ban on Huawei was expected to be met with strong oppositions from the industry and even from within the government, including the Brazilian Vice President Hamilton Mourao. The Brazilian Minister for Communications Fabio Faria refused to comment on the report, while Heleno has said that he was not involved in affairs pertaining to 5G.
#Brazil #5G #Huawei #JairBolsonaro #AugustoHeleno #HamiltonMourao #FabioFaria #Telecommunication #NationalSecurity #Beijing #ChineseGovernment #PLA #CleanNetwork
Source: Apple Daily #Dec09
https://bit.ly/3sRiRzP
In support of the US’s Clean Network Program, Brazil was looking into legal procedures to restrict national telecommunication companies from using 5G network equipment developed by Huawei. Brazilian President Jair Bolsonaro’s national security advisor was looking into whether or not the government should ban Huawei with a presidential decree. However, as many major telecommunication companies have partnered with Huawei for years, the move was expected to be met with strong opposition.
A report stated that the Secretary of Institutional Security Augusto Heleno was in discussions with the Ministry of Communications to set up security provisions that telecommunication companies and equipment suppliers must comply to. They were also studying into the feasibility of a presidential decree. The US has criticised Huawei for its ties with China’s People’s Liberation Army and has expressed concerns over the leaking of confidential information to the Chinese government, which presents threats to national security.
As China has been Brazil’s most important trade partner, the ban on Huawei was expected to be met with strong oppositions from the industry and even from within the government, including the Brazilian Vice President Hamilton Mourao. The Brazilian Minister for Communications Fabio Faria refused to comment on the report, while Heleno has said that he was not involved in affairs pertaining to 5G.
#Brazil #5G #Huawei #JairBolsonaro #AugustoHeleno #HamiltonMourao #FabioFaria #Telecommunication #NationalSecurity #Beijing #ChineseGovernment #PLA #CleanNetwork
Source: Apple Daily #Dec09
https://bit.ly/3sRiRzP
Brazilian Health Authorities Criticise the Low Transparency of the Chinese Vaccine Emergency Use Standard
Whether using vaccine manufactured by the Chinese company Sinovac Biotech caused controversy in Brazil again and involved in Brazilian partisan debate.
ANVISA, a Brazilian Health Regulatory Agency, expressed their concerns over the COVID-19 vaccines on Monday as the Chinese public health departments approved the vaccine for emergency use without adequate transparency of the policy standards.
Jair Bolsonaro, the President of Brazil, has always criticised the Chinese vaccine that the “origin” of vaccine is not trustworthy. However, his political opponent, Sao Paulo Governor João Doria, who is regarded as the most capable of challenging the presidency in the 2022 presidential election, his state's research institute, is currently developing the vaccine CoronaVac with Sinovac. Doria even mentioned that they expect to distribute the vaccines to the local residents in January 2021.
#Vaccine #COVID19 #CovidVaccine #JoãoDoria #JairBolsonaro #SinovacBiotech #Brazil #ANVISA
Source: Stand News #Dec15
https://bit.ly/3ucWGEW
Whether using vaccine manufactured by the Chinese company Sinovac Biotech caused controversy in Brazil again and involved in Brazilian partisan debate.
ANVISA, a Brazilian Health Regulatory Agency, expressed their concerns over the COVID-19 vaccines on Monday as the Chinese public health departments approved the vaccine for emergency use without adequate transparency of the policy standards.
Jair Bolsonaro, the President of Brazil, has always criticised the Chinese vaccine that the “origin” of vaccine is not trustworthy. However, his political opponent, Sao Paulo Governor João Doria, who is regarded as the most capable of challenging the presidency in the 2022 presidential election, his state's research institute, is currently developing the vaccine CoronaVac with Sinovac. Doria even mentioned that they expect to distribute the vaccines to the local residents in January 2021.
#Vaccine #COVID19 #CovidVaccine #JoãoDoria #JairBolsonaro #SinovacBiotech #Brazil #ANVISA
Source: Stand News #Dec15
https://bit.ly/3ucWGEW
WHO Experts Review the Severe Side Effects Data of Sinovac, Commented "Low Credibility" for Elderly
WHO experts indicated 5 May that the Chinese Sinovac for COVID-19 has protection to adults who are under 60. However, there is a lack of data on the risk of serious side effects from vaccines, with “low credibility” for patients over aged 60 and with chronic illnesses. The expert group even referred to the severe side effect data of Sinovac on the elderly and patients with chronic illness as “very low” credibility.
The Strategic Advisory Group of Experts on Immunization (SAGE) in WHO evaluated the Phase 3 clinical test data of Sinovac in China, Brazil, Indonesia, Turkey, and Chile. They are very confident about the effectiveness of two doses of Sinovac in preventing adults aged 18-59, moderately confident about the severe side effect data on adults aged 59 years or younger. However, for those aged 60 years or older and patients with chronic diseases, the risk data of patients with severe side effects after vaccination is classified as “low credibility”, which means that the test data of Sinovac cannot determine the risks of serious side effects of Sinovac on the elderly and patients.
Source: Stand News #May06
https://bit.ly/3tKkLl3
#WHO #Vaccine #SAGE #COVID19 #China #Sinovac #Brazil #Indonesia #Turkey #Chile #Credibility #Phase3ClinicalTest
WHO experts indicated 5 May that the Chinese Sinovac for COVID-19 has protection to adults who are under 60. However, there is a lack of data on the risk of serious side effects from vaccines, with “low credibility” for patients over aged 60 and with chronic illnesses. The expert group even referred to the severe side effect data of Sinovac on the elderly and patients with chronic illness as “very low” credibility.
The Strategic Advisory Group of Experts on Immunization (SAGE) in WHO evaluated the Phase 3 clinical test data of Sinovac in China, Brazil, Indonesia, Turkey, and Chile. They are very confident about the effectiveness of two doses of Sinovac in preventing adults aged 18-59, moderately confident about the severe side effect data on adults aged 59 years or younger. However, for those aged 60 years or older and patients with chronic diseases, the risk data of patients with severe side effects after vaccination is classified as “low credibility”, which means that the test data of Sinovac cannot determine the risks of serious side effects of Sinovac on the elderly and patients.
Source: Stand News #May06
https://bit.ly/3tKkLl3
#WHO #Vaccine #SAGE #COVID19 #China #Sinovac #Brazil #Indonesia #Turkey #Chile #Credibility #Phase3ClinicalTest
Brazil Stops Purchasing more Coronavac Vaccine and Does not Recommend for the 3rd Dose Booster
Brazil is a major customer of China's Coronavac. However, due to the rising efficacy concerns against the COVID Delta variant, along with other vaccines becoming more accessible, the Brazilian government pauses the Coronavac vaccines purchases and encourages people not to use it for a third booster shot. The CoronaVac vaccine factory originally planned to be built in Brazil is also unknown whether it will be built as scheduled.
The Wall Street Journal mentions that Brazil has almost fully purchased 100 million doses of China’s CoronaVac shot. However, the Brazilian government no longer recommends using CoronaVac as a booster dose, but Pfizer instead due to the low protective rates of CoronaVac.
According to the Brazilian government data, the Chinese shot accounted for 80% of the doses at the beginning of the year due to the National Immunization Programme but now declines to less than 35%. The data also shows two-thirds of Brazilians have had one vaccine shot, and just over a third have had two doses.
Source: Stand News #Sep13
https://bit.ly/39t1w7W
#COVID19 #SinovacBiotech #Coronavac #Pfizer #Brazil #WallStreetJournal #Vaccine #Booster
Brazil is a major customer of China's Coronavac. However, due to the rising efficacy concerns against the COVID Delta variant, along with other vaccines becoming more accessible, the Brazilian government pauses the Coronavac vaccines purchases and encourages people not to use it for a third booster shot. The CoronaVac vaccine factory originally planned to be built in Brazil is also unknown whether it will be built as scheduled.
The Wall Street Journal mentions that Brazil has almost fully purchased 100 million doses of China’s CoronaVac shot. However, the Brazilian government no longer recommends using CoronaVac as a booster dose, but Pfizer instead due to the low protective rates of CoronaVac.
According to the Brazilian government data, the Chinese shot accounted for 80% of the doses at the beginning of the year due to the National Immunization Programme but now declines to less than 35%. The data also shows two-thirds of Brazilians have had one vaccine shot, and just over a third have had two doses.
Source: Stand News #Sep13
https://bit.ly/39t1w7W
#COVID19 #SinovacBiotech #Coronavac #Pfizer #Brazil #WallStreetJournal #Vaccine #Booster